Repurposing of carbamazepine for treatment of skeletal dysplasia

Projektinformationen

MCDS-Therapy

ID Finanzhilfevereinbarung: 754825

DOI

10.3030/754825

Projekt abgeschlossen

EK-Unterschriftsdatum 5 Dezember 2017

Startdatum 1 Dezember 2017

Enddatum 31 Mai 2024

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten

€ 5 697 390,50

EU-Beitrag

€ 5 697 390,50

Koordiniert durch

UNIVERSITY OF NEWCASTLE UPON TYNE
United Kingdom

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Websites, patent fillings, videos etc. (1)

MCDS-Therapy website destined for scientific and public communities

Provide a project specific website to regularly disseminate uptodate information on the project to all stake holders.

Documents, reports (7)

Final estimates of BIA

Revised and updated estimates of the net cost of implementing the therapy in a target health care system using data produced from the whole programme of work.

Final estimates of CEA

Revised and updated estimates of the cost-effectiveness of the therapy in a target health care system using data produced from the whole programme of work.

Annual newsletter at M24

Continue newsletter dissemination. Develop patient focussed components to keep participants up to date with study.

Annual newsletter at M48

Share the findings of the project with our established audience in a tailored manner Communicate our future goals and their role in these

Annual newsletter at M36

Continue newsletter dissemination. Aim to share progress of wider publicity and awareness work. Engage network in this.

Report on patient and carer preferences

The reactive importance of different aspects of a new package of care for MCDS.

Annual newsletter at M12

Plan and release a simple and accessible newletter to update both patients and interested parties on project aims.

Other (1)

Executable BIA and economic evaluation models

Models that can be used and adapted by health care decision-makers to estimate locally relevant estimates of budget impact and cost-effectiveness.

Demonstrators, pilots, prototypes (1)

Conceptual models for BIA and economic evaluation

Conceptual BIA and CEA models will be developed by mapping the natural history of disease and the sequence of care provided in each of the UK, Germany and Italy.

Veröffentlichungen

Peer reviewed articles (1)

Interventions for improving clinical outcomes and health-related quality-of-life for people living with skeletal dysplasias: an evidence gap map

Autoren: Moy N.; Flynn D.; Henriquez J.; Connelly L. B.; Vale L.; Paolucci F.
Veröffentlicht in: Crossref, Ausgabe 2, 2023, ISSN 0962-9343
Herausgeber: Kluwer Academic Publishers
DOI: 10.1007/s11136-023-03431-z